1 August 2020 - The government has reached a deal to have Pfizer and BioNTech supply 120 million doses of a coronavirus vaccine to Japan by the end of June 2021, if the medicine proves effective.

The supply from the U.S. pharmaceutical giant and its German partner is enough to treat 60 million people.

“We’re advancing talks with other companies too,” health minister Katsunobu Kato told reporters Friday. “We’ll strive to supply a safe and effective vaccine at the earliest opportunity.”

Read Japan Times article